AVAI (Avai Bio) 5-Year Yield-on-Cost %: 0.00 (As of Jun. 29, 2026)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.15
! 3 Warning Signs
View Full Analysis

What is Avai Bio 5-Year Yield-on-Cost %?

Avai Bio AVAI -6.27% 24 5-Year Yield-on-Cost % is 0.00 as of Jun. 29, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 1,031 Software companies, Avai Bio ranks worse than 96993.11% on this metric.

Avai Bio's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Avai Bio's 5-Year Yield-on-Cost % or its related term are showing as below:



AVAI's 5-Year Yield-on-Cost % is not ranked *
in the Software industry.
Industry Median: 3.15
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Avai Bio  (OTCPK:AVAI) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Avai Bio 5-Year Yield-on-Cost % Related Terms

AVAI vs IPM, RCT, LPSN: 5-Year Yield-on-Cost % Comparison

For the Software - Application subindustry, Avai Bio's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avai Bio 5-Year Yield-on-Cost % vs Software Industry

For the Software industry and Technology sector, Avai Bio's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Avai Bio's 5-Year Yield-on-Cost % falls into.


AVAI
24GF Score
Avai Bio Inc AVAI
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avai Bio 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Avai Bio is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Avai Bio (AVAI) has a 5-Year Yield-on-Cost % of 0.00 as of Jun. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #999999 out of 1031 companies in the Software industry.
Is Avai Bio's 5-Year Yield-on-Cost % too high?
Avai Bio's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Avai Bio ranks #999999 out of 1031 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's 5-Year Yield-on-Cost % compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #999999 out of 1031 companies for 5-Year Yield-on-Cost %. This places Avai Bio in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Software company?
The median 5-Year Yield-on-Cost % among Software companies is 3.15, based on 1,031 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Avai Bio and its competitors. For the Software industry, the median 5-Year Yield-on-Cost % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Avai Bio (AVAI), the current 5-Year Yield-on-Cost % is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price